VAERS reports by lot

GSK Varicella/Shingles lot L9CS4: VAERS reports

72 VAERS reports list lot L9CS4 as a GSK Varicella/Shingles vaccine, received between 2018-07-20 and 2019-03-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
72
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7832%
Injection-site / Local reaction5121%
Musculoskeletal2711%
Neurological2510%
Dermatological (non-injection-site)187%
Allergic / Anaphylactic167%
Gastrointestinal125%
Cardiac / Cardiovascular73%
Respiratory73%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Ohio5
Florida5
Maine4
Pennsylvania4
South Carolina4
California4
Wisconsin4
New Jersey3
Oregon3
New Mexico3
Massachusetts3

Reports by month received

2018-076
2018-0827
2018-0918
2018-109
2018-114
2018-124
2019-011
2019-021
2019-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.